'Do HIV-infected injecting drug users over-report adherence to highly active antiretroviral therapy?' A comparison between patients' self-reports and serum protease inhibitor concentrations in the French Manif 2000 cohort study.
Duran
S
S
INSERM Research Unit 379, Marseille, France.
Solas
C
C
Spire
B
B
Carrieri
M P
MP
Fuzibet
J G
JG
Costagliola
D
D
Lacarelle
B
B
Moatti
J P
JP
D023241:Antiretroviral Therapy, Highly Active; D018791:CD4 Lymphocyte Count; D002851:Chromatography, High Pressure Liquid; D015331:Cohort Studies; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000097:blood* / Q000627:therapeutic use; D006801:Humans; D019469:Indinavir / Q000097:blood* / Q000627:therapeutic use; D010349:Patient Compliance; D015819:Substance Abuse, Intravenous / Q000150:complications / Q000188:drug therapy*
D017320:HIV Protease Inhibitors; D019469:Indinavir